GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Universal Ibogaine Inc (TSXV:IBO) » Definitions » LT-Debt-to-Total-Asset

Universal Ibogaine (TSXV:IBO) LT-Debt-to-Total-Asset : 0.48 (As of Jan. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Universal Ibogaine LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Universal Ibogaine's long-term debt to total assests ratio for the quarter that ended in Jan. 2024 was 0.48.

Universal Ibogaine's long-term debt to total assets ratio increased from Jan. 2023 (0.36) to Jan. 2024 (0.48). It may suggest that Universal Ibogaine is progressively becoming more dependent on debt to grow their business.


Universal Ibogaine LT-Debt-to-Total-Asset Historical Data

The historical data trend for Universal Ibogaine's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Universal Ibogaine LT-Debt-to-Total-Asset Chart

Universal Ibogaine Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Jul22 Jul23
LT-Debt-to-Total-Asset
Get a 7-Day Free Trial - - 0.03 0.03 0.18

Universal Ibogaine Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
LT-Debt-to-Total-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.36 0.43 0.18 0.19 0.48

Universal Ibogaine LT-Debt-to-Total-Asset Calculation

Universal Ibogaine's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Jul. 2023 is calculated as

LT Debt to Total Assets (A: Jul. 2023 )=Long-Term Debt & Capital Lease Obligation (A: Jul. 2023 )/Total Assets (A: Jul. 2023 )
=0.962/5.502
=0.17

Universal Ibogaine's Long-Term Debt to Total Asset Ratio for the quarter that ended in Jan. 2024 is calculated as

LT Debt to Total Assets (Q: Jan. 2024 )=Long-Term Debt & Capital Lease Obligation (Q: Jan. 2024 )/Total Assets (Q: Jan. 2024 )
=2.666/5.607
=0.48

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Universal Ibogaine  (TSXV:IBO) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.


Universal Ibogaine LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Universal Ibogaine's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Universal Ibogaine (TSXV:IBO) Business Description

Traded in Other Exchanges
Address
400 3rd Avenue South west, Suite 1470, Calgary, AB, CAN, T2P 4H2
Universal Ibogaine Inc develops a platform of addiction treatment clinics, which use ibogaine as a primary modality for the interruption and ideally cessation of addictions to primarily opioids such as oxycodone, heroin, fentanyl, as well as alcohol, cocaine, and other stimulants. It runs addiction clinics it has a research partner clinic in Mexico.
Executives
Ian Rabb Senior Officer

Universal Ibogaine (TSXV:IBO) Headlines

No Headlines